Gilead Sciences reported $2.03B in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acorda Therapeutics ACOR:US $ -13890000 387K
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ 940.9M 409.4M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Bristol Myers Squibb BMY:US $ 3197M 9M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 1.82B 600M
Glaxosmithkline GSK:US 1.82B 600M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Johnson & Johnson JNJ:US $ 6941M 599M
Merk MRK:US $ 5711M 652M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Novartis NOVN:VX 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Puma Biotechnology PBYI:US $ 12.06M 12.8M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sangamo Biosciences SGMO:US $ -45734000 473K
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Teva Pharmaceutical Industries TEVA:US 734M 55M
United Therapeutics UTHR:US $ 201.8M 86.2M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
YTE INCY:US $ 260.29M 132.62M